N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer

Author：            

Publisher： Spandidos Publications

E-ISSN： 1791-3004|12|2|2999-3006

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.12, Iss.2, 2015-01, pp. : 2999-3006

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients

By Wilmanns C.   Grossmann J.   Steinhauer S.   Manthey G.   Weinhold B.   Schmitt-Gräff A.   von Specht B.-U.  

Clinical and Experimental Metastasis, Vol. 21, Iss. 1, 2004-01 ,pp. : 75-78

Springer Publishing Company

Access to resources Recommend Favorite

Identification of MXRA5 as a novel biomarker in colorectal cancer

By                

Oncology Letters, Vol. 5, Iss. 2, 2013-01 ,pp. : 544-548

Spandidos Publications

Access to resources Recommend Favorite

S100A10 as a novel biomarker in colorectal cancer

By Shang Jinfu   Zhang Zhanxue   Song Weiqing   Zhou Baojun   Zhang Yuesheng   Li Guixin   Qiu Shaofan  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3785-3790

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival

By Lu Guifang   Shan Tao   He Shuixiang   Ren Mudan   Zhu Meng   Hu Yannan   Lu Xinlan   Zhang Dan  

Oncology Reports, Vol. 30, Iss. 5, 2013-11 ,pp. : 2238-2244

Spandidos Publications

Access to resources Recommend Favorite